U.S. Trade Representative Robert Lighthizer is trying to convince skeptical Democrats that the U.S.-Mexico-Canada Agreement will do enough to address their concerns over drug pricing and enforcement of labor and environmental standards.
To view this article, please
login. If you are not a current subscriber, you may sign up for a trial or view other subscription options
here.
